Rezolute Inc (RZLT)
2.855
-0.68
(-19.12%)
USD |
NASDAQ |
Apr 23, 16:00
2.855
0.00 (0.00%)
After-Hours: 18:11
Rezolute Enterprise Value: 47.28M for April 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 22, 2024 | 47.28M |
| April 19, 2024 | 43.32M |
| April 18, 2024 | 38.17M |
| April 17, 2024 | 35.79M |
| April 16, 2024 | 42.13M |
| April 15, 2024 | 29.45M |
| April 12, 2024 | 14.39M |
| April 11, 2024 | 10.43M |
| April 10, 2024 | 3.295M |
| April 09, 2024 | 6.465M |
| April 08, 2024 | 7.654M |
| April 05, 2024 | 0.9177M |
| April 04, 2024 | -1.064M |
| April 03, 2024 | 1.710M |
| April 02, 2024 | -1.856M |
| April 01, 2024 | 3.295M |
| March 28, 2024 | 8.446M |
| March 27, 2024 | -3.837M |
| March 26, 2024 | -8.592M |
| March 25, 2024 | -17.71M |
| March 22, 2024 | -13.35M |
| March 21, 2024 | -16.52M |
| March 20, 2024 | -16.91M |
| March 19, 2024 | -17.31M |
| March 18, 2024 | -21.67M |
| Date | Value |
|---|---|
| March 15, 2024 | -22.06M |
| March 14, 2024 | -20.48M |
| March 13, 2024 | -16.52M |
| March 12, 2024 | -15.33M |
| March 11, 2024 | -13.35M |
| March 08, 2024 | -17.31M |
| March 07, 2024 | -20.88M |
| March 06, 2024 | -21.47M |
| March 05, 2024 | -22.06M |
| March 04, 2024 | -16.52M |
| March 01, 2024 | -21.27M |
| February 29, 2024 | -27.22M |
| February 28, 2024 | -28.40M |
| February 27, 2024 | -25.63M |
| February 26, 2024 | -27.61M |
| February 23, 2024 | -24.44M |
| February 22, 2024 | -29.20M |
| February 21, 2024 | -34.35M |
| February 20, 2024 | -35.14M |
| February 16, 2024 | -39.10M |
| February 15, 2024 | -44.65M |
| February 14, 2024 | -43.46M |
| February 13, 2024 | -49.41M |
| February 12, 2024 | -47.43M |
| February 09, 2024 | -50.60M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-103.50M
Minimum
Dec 19 2022
194.45M
Maximum
Oct 14 2020
13.49M
Average
13.39M
Median
Oct 03 2019
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.139M |
| Palatin Technologies Inc | 18.27M |
| iBio Inc | 16.07M |
| Theriva Biologics Inc | -13.17M |
| Oragenics Inc | 3.172M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -13.91M |
| Total Expenses (Quarterly) | 15.19M |
| EPS Diluted (Quarterly) | -0.27 |
| Earnings Yield | -38.53% |